/Viatris%20Inc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
With a market cap of $11.3 billion, Viatris Inc. (VTRS) is a global pharmaceutical company headquartered in Pennsylvania with operations in over 165 countries. Its portfolio spans generic and branded medicines, biosimilars, and APIs, covering key therapeutic areas like cardiovascular, oncology, CNS, women’s health, and gastroenterology.
Companies worth $10 billion or more are generally described as "large-cap stocks." Viatris fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the specialty & generic drug manufacturing industry.